INFUSYSTEM HOLDINGS, INC Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- INFUSYSTEM HOLDINGS, INC payments for repurchase of common stock for the quarter ending 2026-06-30 was $3.55M, a 1.40% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC payments for repurchase of common stock for the quarter ending 2026-03-31 was $809.00K, a 72.06% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC payments for repurchase of common stock for the quarter ending 2025-12-31 was $1.31M, a 556.28% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC payments for repurchase of common stock for the quarter ending 2025-09-30 was $2.17M, a 210.60% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC payments for repurchase of common stock for fiscal 2025 was $9.87M, a 736.36% increase from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC payments for repurchase of common stock for fiscal 2024 was $1.18M, a 671.24% increase from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC payments for repurchase of common stock for fiscal 2023 was $153.00K, a 97.20% decline from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC payments for repurchase of common stock for fiscal 2022 was $5.46M, a 874.82% increase from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $3.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $7.83M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $809.00K 10-Q · filed 2026-05-08 | $7.78M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.87M 10-K · filed 2026-02-27 |
| 2025-09-30 | $2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $8.76M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $7.29M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $2.90M 10-Q · filed 2026-05-08 | $4.08M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $199.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.18M 10-K · filed 2026-02-27 |
| 2024-09-30 | $698.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $981.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $283.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $153.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $253.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $1.26M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $153.00K 10-Q · filed 2024-05-09 | $1.61M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $5.46M 10-K · filed 2024-04-10 |
| 2022-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $5.92M derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-06-30 | $350.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $4.92M derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-03-31 | $4.01M 10-Q · filed 2023-05-09 | $4.57M derived: sum of 4 quarters · filed 2024-04-10 |
| 2021-12-31 | $560.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $560.00K 10-K · filed 2024-04-10 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | |
| 2020-12-31 | $0.00 10-K · filed 2023-03-16 | |
| 2019-12-31 | $0.00 10-K · filed 2022-03-15 | |
| 2018-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $10.39M 10-K · filed 2020-03-30 |
| 2018-09-30 | $9.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | |
| 2018-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | |
| 2018-03-31 | $83.00K 10-Q · filed 2019-05-15 | |
| 2017-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $52.00K derived: sum of 4 quarters · filed 2017-11-13 |
| 2017-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $70.00K derived: sum of 4 quarters · filed 2017-11-13 |
| 2017-03-31 | $20.00K 10-Q · filed 2017-05-15 | $62.00K derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $75.00K 10-K · filed 2017-03-22 |
| 2016-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $85.00K derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $164.00K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | $33.00K 10-Q · filed 2017-05-15 | |
| 2015-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $179.00K 10-K · filed 2017-03-22 |
| 2015-09-30 | $96.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-12-12 | |
| 2014-12-31 | $26.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-12-12 | $204.00K 10-K/A · filed 2016-12-12 |
| 2014-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | |
| 2013-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $79.00K 10-K · filed 2015-03-09 |
| 2013-09-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | |
| 2012-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $144.00K 10-K · filed 2014-03-11 |
| 2012-09-30 | $99.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | |
| 2011-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $363.00K 10-K · filed 2013-03-28 |
| 2011-09-30 | $95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | |
| 2011-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | |
| 2011-03-31 | $229.00K 10-Q · filed 2012-05-21 | |
| 2010-12-31 | $68.00K 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |